Patent details

EP2792369 Title: Bendamustine cyclopolysaccharide compositions

Basic Information

Publication number:
EP2792369
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP141773069
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Bendamustine cyclopolysaccharide compositions
French Title of Invention:
Compositions cyclopolysaccharide de bendamustine
German Title of Invention:
Bendamustin-Cyclopolysaccharidzusammensetzungen
SPC Number:

Dates

Filing date:
24/02/2010
Grant date:
18/04/2018
EP Publication Date:
22/10/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/04/2018
EP B1 Publication Date:
18/04/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/02/2019
Expiration date:
24/02/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/04/2018
 
 

Name:
Softkemo Pharma Corp.
Address:
1080 Côte du Beaver Hall, Suite 1610, Montreal, QC H2Z 1S8, Canada (CA)

Inventor

1

Name:
Pietrzynski, Grzegorz
Address:
Canada (CA)

2

Name:
Alakhov, Valery
Address:
Canada (CA)

3

Name:
Patel, Kishore
Address:
Canada (CA)

4

Name:
Popek, Tomasz
Address:
Canada (CA)

Priority

1

Priority Number:
208541 P
Priority Date:
25/02/2009
Priority Country:
United States (US)

2

Priority Number:
269944 P
Priority Date:
01/07/2009
Priority Country:
United States (US)

3

Priority Number:
271364 P
Priority Date:
20/07/2009
Priority Country:
United States (US)

4

Priority Number:
279293 P
Priority Date:
19/10/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4184; A61K 47/40; A61K 47/42;

Publication

European Patent Bulletin

1

Issue number:
201816
Publication date:
18/04/2018
Description:
Grant (B1)

2

Issue number:
202033
Publication date:
12/08/2020
Description:
Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages